Company profile
Caris Life Sciences, Inc. Insider Trading
CAIEvery SEC Form 4 insider trading filing for Caris Life Sciences, Inc. (CAI) since April 2023: open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Services-Medical Laboratories
- CIK
- 0002019410
- Filings
- 50
- Insiders
- 24
- Last filing
- 2026-09-22
Activity summary
Recent insider activity is bearish. Over the last 30 days, insiders net sold $27.2M across 5 transactions.
Quarterly balance
Buy and sell value by quarter, Q1 25 to Q3 26. Caris Life Sciences, Inc. insiders are net sellers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $27.2M.
90 day insight
Over the last 90 days, Caris Life Sciences, Inc. insiders sold $27.2M across 5 transactions with no open-market purchases.
- Most active insider: David Baxley Spetzler with 7 transactions totaling $17.9M.
- Largest single sale: $12.1M by Brian J Brille on Sep 17, 2026.
Activity skews bearish: sales outpace buys.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
Showing 5 of 50 transactions. The most significant are picked first.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 17, 2026 | Brian J Brille | CAI | Sale | 400,000 | $30.33 | $12.13M |
| Sep 3, 2026 | David Baxley Spetzler | CAI | Sale | 393,100 | $24.76 | $9.73M |
| May 15, 2026 | Jon Halbert | CAI | Purchase | 68,000 | $14.56 | $990K |
| May 11, 2026 | Jeff L Vacirca | CAI | Purchase | 31,050 | $16.15 | $501K |
| Nov 7, 2025 | John Russel Denton | CAI | Purchase | 4,184 | $24.09 | $101K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=CAI" \
-H "X-Api-Key: $KEY"Get a keyTop insiders
By open-market value traded.
Institutional Ownership
Top 13F-HR holders of Caris Life Sciences, Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings: institutional holders report positions within 45 days of quarter end. Joined with insider activity above: see who's loading up institutionally while insiders are trading. Full 13F-HR API →